Cerus Corporation
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.
Traded as | Nasdaq: CERS |
|---|---|
| Industry | Biotechnology |
| Founded | September 1991 as Cerus Technologies Inc |
| Headquarters | Concord, California, United States |
Key people | President and CEO William 'Obi' M. Greenman |
| Products | Blood transfusion products |
| Revenue | $74.649 million (2019) |
Number of employees | 254 (2019) |
| Website | www |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.